INS and Hypoglycemia: Importantly, Smad3-deficient mice show a slightly higher level of blood insulin, pancreatic insulin content, and moderate hypoglycemia with augmented glucose tolerance, although these mice have similar islet morphology and β cell mass compared with the wild-type mice [41].